Keywords: Roche, Zelboraf, Melanoma, UK, NICE

UK's NICE delays decision on Roche's Zelboraf, asking for more information

Article | 10 August 2012

UK health care watchdog the National Institute for Health and Clinical Excellence (NICE) today (August 10) issued draft guidance requesting Swiss ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Zelboraf

Go to drug listing